top of page
Search


Report Shines Light on Dangers of Third-Party Litigation Funding on American Patients
Washington Health Innovation Council Releases Comprehensive Report On The Dangers Of Third-Party Litigation Funding On American Patients
WHIC
Feb 273 min read
135 views


Building Momentum in a New Year
Washington Health Innovation Meeting Recap - January 30th, 2025 The first Washington Health Innovation Council (WHIC) meeting...
Jack Kalavritinos
Jan 312 min read
20 views
0 comments
JK Strategies 2024 Holiday Party
Thank you to all our JKS partners and friends for joining us for our annual holiday gathering!
Jenni Mushynski
Dec 6, 20241 min read
21 views
0 comments


Policy Update from the Washington Health Innovation Council
July 2024 | Washington D.C. -- Throughout 2024 the Washington Health Innovation Council (WHIC) has featured challenges facing the rare...
Mia Heck
Jul 2, 20243 min read
4 views
0 comments

The US Chamber Hosts Partners and Allies of the Washington Health Innovation Council as well as Rep. Bilirakis and the Healthcare Advisor to the Speaker of House
June 26, 2024 Washington D.C. -- The WHIC had a serious set of discussions revolving around the IP confiscation proposal, the U.S Chamber...
Jack Kalavritinos
Jun 26, 20243 min read
83 views


The US Chamber Hosts Partners and Allies of the Washington Health Innovation Council as well as Rep. Bilirakis and the Healthcare Advisor to the Speaker of House
June 26, 2024 | Washington D.C. -- The WHIC had a serious set of discussions revolving around the IP confiscation proposal, the U.S...
Jack Kalavritinos
Jun 26, 20243 min read
4 views


Priorities and Patient Advocacy Going into 2025: WHIC Meeting Recap
May 20, 2024 Washington, D.C.-- At the DC headquarters of the American Academy of Ophthalmology, our Washington Health Innovation...
Jack Kalavritinos
May 31, 20245 min read
70 views


Despite Healthcare Advances, Challenges with Treating and Curing Rare Diseases Persist as IRA and FDA Policies Create Legislative and Regulatory Hurdles
WHIC's recent discussion about rare diseases and the promise and the hurdles was both powerful and disheartening.
Jack Kalavritinos
Apr 24, 20243 min read
106 views
bottom of page